🦊/Companies

Motion

2 known investors

Find your way into Motion

AxioMed develops motion-preserving spinal disc replacement technologies designed to treat early-stage spine degeneration, shifting care away from fusion surgery toward minimally invasive procedures performed in ambulatory surgery centers. The company targets the spine surgery market in the United States with patented biomimetic disc technologies that restore natural spinal mechanics.

Investors · 2

Also in the syndicate · 1

Extantialead

Funding

SEC filings, press & company announcements
  • Undisclosed amountpre-seedAug 2026

    Extantia (lead)

    Source ↗
  • Undisclosed amountSeries CMay 2026
    Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does Motion do?
AxioMed develops motion-preserving spinal disc replacement technologies designed to treat early-stage spine degeneration, shifting care away from fusion surgery toward minimally invasive procedures performed in ambulatory surgery centers. The company targets the spine surgery market in the United States with patented biomimetic disc technologies that restore natural spinal mechanics.
Who are Motion's investors?
Motion's investors include KIC Ventures.